Trademarkia Logo

Canada

C$
ELEVATEBIO BASECAMP
SEARCHED

on 22 Jul 2024

Last Applicant/ Owned by

ElevateBio, LLC

One Main StreetCambridge, MA 02142

US

Serial Number

1968512 filed on 10th Jun 2019

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

CA

K1P5Y6

ELEVATEBIO BASECAMP

Trademark usage description

operation of a cell and gene therapy facility. business of research, development, manufacturing of pharmaceuticals and medical devices. operation of a Read More

Classification Information


Class [035]
Operation of a cell and gene therapy facility. Business of research, development, manufacturing of pharmaceuticals and medical devices. Operation of a business in the field of research, development, manufacturing of pharmaceuticals and medical devices. Advice relating to the organisation and management of business; Advisory services for business management; Advisory services relating to business management and business operations; business management and advice; Business management assistance; Business management assistance for industrial or commercial companies; Business management consultancy services; Providing advice and information relating to commercial business management


Classification kind code

11

Class [040]
Treatment of materials


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [041]
Education and entertainment


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Business of research, development, manufacturing of pharmaceuticals and medical devices. Business portfolio management and research and development in pharmaceuticals and medical devices. Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy


Classification kind code

11

Class [044]
Medical and veterinary, beauty, agricultural and forestry


Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details


Serial Number

1968512

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 15
on 6th Feb 2025
Correspondence Created
Submitted for opposition 22
on 22nd Jul 2024
Search Recorded
Submitted for opposition 20
on 22nd Jul 2024
Examiner's First Report
Submitted for opposition 67
on 29th Sept 2023
Agent Name Changed
Submitted for opposition 287
on 9th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 48
on 2th Nov 2021
Agent Changed
Submitted for opposition 31
on 13th Jun 2019
Formalized
Submitted for opposition 1
on 11th Jun 2019
Created
Submitted for opposition 30
on 10th Jun 2019
Filed